Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myeloid Leukemia in Relapse (Disorder)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00526292
What this trial is testing

Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Donor Stem Cell Transplant

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Memorial Sloan Kettering Cancer Center 12
Early research (Phase 1)Study completedNCT00462761
What this trial is testing

A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status

Who this might be right for
Acute Myeloid LeukemiaLeukemiaMyelodysplastic Syndrome+2 more
Daiichi Sankyo 76
Early research (Phase 1)Looking for participantsNCT05549661
What this trial is testing

Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms

Who this might be right for
Recurrent Chronic Myelomonocytic LeukemiaRefractory Chronic Myelomonocytic LeukemiaMyelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified+3 more
Mayo Clinic 25
Early research (Phase 1)Study completedNCT03564288
What this trial is testing

Study to Find a Safe and Effective Dose of SKI-G-801 in the Treatment of Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Oscotec Inc. 14
Testing effectiveness (Phase 2)Ended earlyNCT04550442
What this trial is testing

Venetoclax and Azacitidine for the Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Who this might be right for
Recurrent Chronic Myelomonocytic LeukemiaRecurrent Myelodysplastic SyndromeRefractory Chronic Myelomonocytic Leukemia+2 more
M.D. Anderson Cancer Center 34
Large-scale testing (Phase 3)Ended earlyNCT02545283
What this trial is testing

Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Leukemia, Myeloid, Acute
Hoffmann-La Roche 447
Not applicableStudy completedNCT00053157
What this trial is testing

Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+3 more
Roswell Park Cancer Institute 10
Early research (Phase 1)Looking for participantsNCT05190471
What this trial is testing

A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia Refractory
Bio-Path Holdings, Inc. 48
Testing effectiveness (Phase 2)UnknownNCT01950611
What this trial is testing

Proteasome Inhibition in Acute Promyelocytic Leukemia

Who this might be right for
Relapsed Acute Promyelocytic Leukemia
Christian Medical College, Vellore, India 30
Not applicableStudy completedNCT00342316
What this trial is testing

Reduced Intensity Conditioning Transplantation Versus Standard of Care in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Vastra Gotaland Region 340
Early research (Phase 1)Study completedNCT00990587
What this trial is testing

Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic Malignancy

Who this might be right for
Hematologic MalignancyAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+4 more
University Health Network, Toronto 20
Not applicableEnded earlyNCT01326728
What this trial is testing

Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Chronic Myelogenous LeukemiaAcute Myelogenous LeukemiaAcute Lymphoblastic Leukemia+2 more
National Cancer Institute (NCI) 56
Large-scale testing (Phase 3)Study completedNCT00003938
What this trial is testing

Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 115
Testing effectiveness (Phase 2)Study completedNCT02257138
What this trial is testing

Ruxolitinib Phosphate and Decitabine in Treating Patients With Relapsed or Refractory or Post Myeloproliferative Acute Myeloid Leukemia

Who this might be right for
Blasts More Than 20 Percent of Bone Marrow Nucleated CellsBlasts More Than 20 Percent of Peripheral Blood White CellsMyelodysplastic/Myeloproliferative Neoplasm+2 more
M.D. Anderson Cancer Center 30
Early research (Phase 1)Ended earlyNCT03516760
What this trial is testing

Dose-escalating Phase I Trial With GEM333 in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaRelapsed AMLRefractory AML
AvenCell Europe GmbH 36
Testing effectiveness (Phase 2)Study completedNCT00363974
What this trial is testing

Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML

Who this might be right for
Leukemia, Myelomonocytic, Acute
Aegera Therapeutics 54
Early research (Phase 1)Study completedNCT00357708
What this trial is testing

Vorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer or Other Diseases

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+10 more
National Cancer Institute (NCI) 50
Early research (Phase 1)Study completedNCT01398462
What this trial is testing

Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome+1 more
JW Pharmaceutical 69
Testing effectiveness (Phase 2)Study completedNCT00002674
What this trial is testing

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center 30
Testing effectiveness (Phase 2)Ended earlyNCT01034410
What this trial is testing

AS1411 Combined With Cytarabine in the Treatment of Patients With Primary Refractory or Relapsed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Antisoma Research 90
Next Page